| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.24 | 0.4 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.21 | 0.5 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.06 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.17 | 0.004 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0008 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |